These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 28341836

  • 1. FAM46C is critical for the anti-proliferation and pro-apoptotic effects of norcantharidin in hepatocellular carcinoma cells.
    Zhang QY, Yue XQ, Jiang YP, Han T, Xin HL.
    Sci Rep; 2017 Mar 24; 7(1):396. PubMed ID: 28341836
    [Abstract] [Full Text] [Related]

  • 2. NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling.
    Zhang S, Yang Y, Hua Y, Hu C, Zhong Y.
    Mol Med Rep; 2020 Aug 24; 22(2):774-782. PubMed ID: 32468032
    [Abstract] [Full Text] [Related]

  • 3. Antimetastatic effects of norcantharidin on hepatocellular carcinoma cells by up-regulating FAM46C expression.
    Wan XY, Zhai XF, Jiang YP, Han T, Zhang QY, Xin HL.
    Am J Transl Res; 2017 Aug 24; 9(1):155-166. PubMed ID: 28123642
    [Abstract] [Full Text] [Related]

  • 4. Norcantharidin combined with ABT-737 for hepatocellular carcinoma: Therapeutic effects and molecular mechanisms.
    Ren J, Li G, Zhao W, Lin L, Ye T.
    World J Gastroenterol; 2016 Apr 21; 22(15):3962-8. PubMed ID: 27099439
    [Abstract] [Full Text] [Related]

  • 5. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells.
    Liang L, Zhao L, Wang Y, Wang Y.
    Mol Pharm; 2021 Mar 01; 18(3):1003-1013. PubMed ID: 33527831
    [Abstract] [Full Text] [Related]

  • 6. Norcantharidin inhibits IL-6-induced epithelial‑mesenchymal transition via the JAK2/STAT3/TWIST signaling pathway in hepatocellular carcinoma cells.
    Gao Y, Li W, Liu R, Guo Q, Li J, Bao Y, Zheng H, Jiang S, Hua B.
    Oncol Rep; 2017 Aug 01; 38(2):1224-1232. PubMed ID: 28677802
    [Abstract] [Full Text] [Related]

  • 7. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
    Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, Hsu SL.
    Int J Cancer; 2002 Jul 10; 100(2):158-65. PubMed ID: 12115564
    [Abstract] [Full Text] [Related]

  • 8. Norcantharidin enhances ABT-737-induced apoptosis in hepatocellular carcinoma cells by transcriptional repression of Mcl-1.
    Zhang S, Li G, Ma X, Wang Y, Liu G, Feng L, Zhao Y, Zhang G, Wu Y, Ye X, Qin B, Lu J.
    Cell Signal; 2012 Sep 10; 24(9):1803-9. PubMed ID: 22609455
    [Abstract] [Full Text] [Related]

  • 9. Norcantharidin combined with Coix seed oil synergistically induces apoptosis and inhibits hepatocellular carcinoma growth by downregulating regulatory T cells accumulation.
    Wang D, Yang C, Wang Z, Yang Y, Li D, Ding X, Xu W, Zheng Q.
    Sci Rep; 2017 Aug 24; 7(1):9373. PubMed ID: 28839202
    [Abstract] [Full Text] [Related]

  • 10. Folate receptor-targeted liposomes loaded with a diacid metabolite of norcantharidin enhance antitumor potency for H22 hepatocellular carcinoma both in vitro and in vivo.
    Liu MC, Liu L, Wang XR, Shuai WP, Hu Y, Han M, Gao JQ.
    Int J Nanomedicine; 2016 Aug 24; 11():1395-412. PubMed ID: 27110110
    [Abstract] [Full Text] [Related]

  • 11. Contribution of p38 MAPK Pathway to Norcantharidin-Induced Programmed Cell Death in Human Oral Squamous Cell Carcinoma.
    Ahn CH, Hong KO, Jin B, Lee W, Jung YC, Lee H, Shin JA, Cho SD, Hong SD.
    Int J Mol Sci; 2019 Jul 16; 20(14):. PubMed ID: 31315217
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
    Fan YZ, Fu JY, Zhao ZM, Chen CQ.
    Hepatobiliary Pancreat Dis Int; 2007 Feb 16; 6(1):72-80. PubMed ID: 17287171
    [Abstract] [Full Text] [Related]

  • 13. Cantharidin exerts anti-hepatocellular carcinoma by miR-214 modulating macrophage polarization.
    Lu S, Gao Y, Huang X, Wang X.
    Int J Biol Sci; 2014 Feb 16; 10(4):415-25. PubMed ID: 24719559
    [Abstract] [Full Text] [Related]

  • 14. Induction of apoptosis in human Hep3B hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction.
    Yeh CH, Yang YY, Huang YF, Chow KC, Chen MF.
    Chin J Integr Med; 2012 Sep 16; 18(9):676-82. PubMed ID: 22936321
    [Abstract] [Full Text] [Related]

  • 15. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
    Mei L, Sang W, Cui K, Zhang Y, Chen F, Li X.
    Cancer Sci; 2019 Feb 16; 110(2):582-595. PubMed ID: 30520540
    [Abstract] [Full Text] [Related]

  • 16. Regulation of demethylation and re-expression of RASSF1A gene in hepatocellular carcinoma cell lines treated with NCTD in vitro.
    Wang Y, Xu M, Di ZH, Zhang J, Mao XQ, Sun HB.
    J Cancer Res Ther; 2015 Feb 16; 11(4):818-22. PubMed ID: 26881524
    [Abstract] [Full Text] [Related]

  • 17. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
    Yu CC, Ko FY, Yu CS, Lin CC, Huang YP, Yang JS, Lin JP, Chung JG.
    Int J Oncol; 2012 Sep 16; 41(3):1050-60. PubMed ID: 22684608
    [Abstract] [Full Text] [Related]

  • 18. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
    Gao B, Luo J, Liu Y, Su S, Fu S, Yang X, Li B.
    Int J Nanomedicine; 2021 Sep 16; 16():4073-4085. PubMed ID: 34163160
    [Abstract] [Full Text] [Related]

  • 19. Atg5 siRNA inhibits autophagy and enhances norcantharidin-induced apoptosis in hepatocellular carcinoma.
    Xiong X, Wu M, Zhang H, Li J, Lu B, Guo Y, Zhou T, Guo H, Peng R, Li X, Tian Q, Wang Y.
    Int J Oncol; 2015 Oct 16; 47(4):1321-8. PubMed ID: 26240015
    [Abstract] [Full Text] [Related]

  • 20. In-vivo anti-tumor activity of a novel poloxamer-based thermosensitive in situ gel for sustained delivery of norcantharidin.
    Xie MH, Ge M, Peng JB, Jiang XR, Wang DS, Ji LQ, Ying Y, Wang Z.
    Pharm Dev Technol; 2019 Jun 16; 24(5):623-629. PubMed ID: 30457414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.